Circulating Tumor DNA
Often known as a “Liquid Biopsy”.
Tumors shed small DNA fragments into the bloodstream. This cell‐free DNA is in contrast with circulating tumor cells (CTCs), which are intact tumor cells in the blood stream.
Our innovative SMSEQ Platform can detect these rare ctDNA fragments with over >99.999% specificity. Using an optimized form of next-generation sequencing (NGS), the SMSEQ technology isolates and deep sequences thousands of base pairs in order to create an accurate genomic tumor profile.